Free Trial

Nektar Therapeutics (NKTR) Insider Trading & Ownership

→ top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad)
Free nktr Stock Alerts
$1.42
+0.06 (+4.41%)
(As of 04/23/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Nektar Therapeutics (NASDAQ:NKTR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.07%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$99,202.16
Get NKTR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nektar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NKTR Insider Buying and Selling by Quarter

Ad Traders Agency
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Nektar Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/20/2024Howard W RobinCEOSell20,033$0.68$13,622.44  
2/20/2024Jonathan ZalevskyInsiderSell9,014$0.68$6,129.52  
11/17/2023Howard W RobinCEOSell19,877$0.49$9,739.73  
11/17/2023Jonathan ZalevskyInsiderSell9,646$0.49$4,726.54  
9/18/2023Myriam CuretDirectorSell4,359$0.69$3,007.71  
8/16/2023Howard W RobinCEOSell19,998$0.78$15,598.44  
8/16/2023Jonathan ZalevskyInsiderSell9,703$0.78$7,568.34  
6/14/2023Roy A WhitfieldDirectorSell30,000$0.57$17,100.00  
5/16/2023Howard W RobinCEOSell20,361$0.72$14,659.92  
5/16/2023Jonathan ZalevskyInsiderSell9,791$0.72$7,049.52  
(Data available from 1/1/2013 forward)

NKTR Insider Trading Activity - Frequently Asked Questions

Who is on Nektar Therapeutics's Insider Roster?

The list of insiders at Nektar Therapeutics includes Gil M Labrucherie, Howard W Robin, Jillian B Thomsen, John Northcott, Jonathan Zalevsky, Karin Eastham, Mark Andrew Wilson, Myriam Curet, Robert Chess, and Roy A Whitfield. Learn more on insiders at NKTR.

What percentage of Nektar Therapeutics stock is owned by insiders?

3.07% of Nektar Therapeutics stock is owned by insiders. Learn more on NKTR's insider holdings.

Which Nektar Therapeutics insiders have been selling company stock?

The following insiders have sold NKTR shares in the last 24 months: Gil M Labrucherie ($68,919.60), Howard W Robin ($458,017.90), Jillian B Thomsen ($103,030.66), Jonathan Zalevsky ($583,631.47), Karin Eastham ($76,773.87), Mark Andrew Wilson ($27,566.84), Myriam Curet ($16,273.39), and Roy A Whitfield ($17,100.00).

How much insider selling is happening at Nektar Therapeutics?

Insiders have sold a total of 469,059 Nektar Therapeutics shares in the last 24 months for a total of $1,351,313.73 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:NKTR) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
This military-backed stock “owns” AI market
Porter & Company
Great Crypto Bull
Weiss Ratings
Double your money before lunch?
Behind the Markets
Fed launches fourth dollar overhaul
Stansberry Research